PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462935
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462935
Urethral Dilators Market size was valued at USD 354.5 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.
Urethral dilators serve as medical instruments utilized to widen and enlarge the urethra, the conduit responsible for transporting urine from the bladder out of the body. They are frequently employed in urological procedures aimed at addressing conditions such as urethral strictures, where the urethra becomes constricted due to scar tissue or inflammation, resulting in difficult or painful urination. These dilators come in various configurations, encompassing simple tapered rods to more intricate devices featuring inflatable balloons or graduated sizes. During the procedure, the dilator is inserted into the urethra and progressively expanded to stretch and broaden the narrowed area, facilitating enhanced urine flow and alleviation of symptoms. Urologists and other medical practitioners utilize urethral dilators as part of a comprehensive treatment regimen to effectively manage urethral strictures and other urological ailments.
Urethral Dilators Market- Market Dynamics
High prevalence of chronic kidney diseases, increasing occurrences of urinary stones and urinary tract infections to propel market demand
The demand for urethral dilators is on the rise due to high prevalence of chronic kidney diseases, increasing occurrences of urinary stones and urinary tract infections, and the rapidly expanding baby boomer population. Urethral dilators are commonly utilized in treating urethral strictures, a condition characterized by the narrowing of the urethra, which impedes the passage of urine. This condition prompts nearly 1.5 million office visits annually in the U.S. The treatment involves inserting a thin rod into the urethra to widen the passage, and in some instances, dilation may be necessary before inserting larger instruments like a resectoscope into the urethra. Individuals afflicted with fibrosis, inflammation, trauma, or birth defects also rely on urethral dilators to expand the urinary tract. Moreover, factors such as the risk of surgical-related infections, the likelihood of recurrence, and the convenience of performing dilation at home are anticipated to drive industry growth in the foreseeable future. The increasing incidence of urethral strictures, prostate cancer, injuries, kidney stones, and other medical conditions necessitating the use of urethral dilators is expected to propel market growth over the forecast period. According to data from Laborie Medical Technologies Inc., a prominent diagnostic and therapeutic medical technology company, urethral stricture is a prevalent ailment among men, with an incidence rate of approximately 1 in every 10,000 at 25 years old, escalating to about 1 in every 1,000 men at 65 years or older. Additionally, a study published by the National Center for Biotechnology Information (NCBI) revealed that in 2018, an estimated 12% of the Indian population suffered from urolithiasis, with 50% of cases potentially leading to kidney function loss and urethral obstructions. Similarly, it is estimated that around 600,000 people in the U.S. grapple with urinary stones annually, translating to 1 in 11 individuals experiencing kidney stones. These factors collectively contribute to the anticipated surge in the sale of urethral dilators in the forthcoming years.
Urethral Dilators Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)
Based on Usage segmentation, disposable was predicted to show maximum market share in the year 2023
Based on End User segmentation, hospitals was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Urethral Dilators Market is segmented on the basis of Usage, Application, End User, and Region.
The market is divided into two categories based on Usage: Disposable and Reusable. The disposable segment accounted for the largest revenue share and is projected to witness the most rapid compound annual growth rate (CAGR) throughout the forecast period. Disposable urethral dilators are designed for single use and are considered a cost-effective option compared to reusable ones. They are preferred over reusable dilators in terms of safety and quality, as they can help mitigate the risk of contamination and transmission of infections between patients. These advantages are expected to drive the growth of this segment over the forecast period.
The market is divided into four categories based on End User: Hospitals, Clinics, Ambulatory Surgical Center and Home Care Settings. The hospitals segment emerged as the dominant player in the global market in 2023. The segment's growth is primarily attributed to the rising number of patients diagnosed with various urological conditions, leading to an uptick in surgical interventions. For instance, according to the Urology Care Foundation, approximately 33 million individuals are living with overactive bladder, and a quarter to a third of men and women in the U.S. experience urinary incontinence (UI). Hospitals are renowned for providing efficient patient care, maintaining safety standards, and offering comprehensive services. Consequently, hospitals are anticipated to experience significant growth during the forecast period. Furthermore, hospitals typically witness a higher influx of patients for urological procedures or other treatments compared to other healthcare settings due to their ability to manage surgical emergencies effectively and provide a wide array of treatment options. Therefore, the hospital segment is poised for growth driven by these factors.
Urethral Dilators Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
In the realm of urethral dilators, companies concentrate on developing innovative devices that offer enhanced safety, efficacy, and patient comfort. They allocate resources to research and development endeavors to craft dilators with advanced attributes like ergonomic handles, smooth surfaces, and precise sizing options, aiming to facilitate ease of use and minimize procedural trauma. Furthermore, companies prioritize adherence to regulatory standards and stringent quality assurance protocols to ensure their products meet the exacting criteria for medical devices. Collaborative ventures with urologists, healthcare establishments, and academic institutions enable companies to glean clinical insights, validate product performance, and refine design iterations based on real-world feedback. By leveraging these strategies, companies endeavor to furnish healthcare professionals with dependable and efficient tools for addressing urethral strictures and other urological conditions, thereby enhancing patient outcomes and quality of life. Market participants continually introduce new products and expand their geographical reach to garner a larger market share.
In June 2020, B. Braun Melsungen AG launched virtual support services during the COVID-19 crisis to assist patients with acute bladder issues at home. This initiative delivers continence and ostomy care products to patients at home through FaceTime video tutorials and guidance on distribution channels.
GLOBAL URETHRAL DILATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
B. Braun Melsungen AG
BD
Cook Medical
MED pro Medical BV
Teleflex Inc.
UROMED
Boston Scientific Corporation
Smiths Medical (ICU Medical)
Urovision-Urotech
Coloplast
Others